Army researchers test tart cherry absorption in new study
NCT ID NCT07063173
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how well the body absorbs and uses healthy compounds from tart cherry when it's eaten in a snack bar or a powdered drink. Researchers will measure these compounds in the blood and urine of 15 healthy adults after they eat the test foods. The goal is to understand if these shelf-stable items provide the same benefits as fresh tart cherry.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 15 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2024
- Expected to finish
-
Dec 2025
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a US federal agency other than the NIH.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
17 to 39 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Active duty military personnel and civilians will be invited to participate in the study if they: * Are between the ages of 18 (or 17 for military personnel) and 39. * Are willing to participate in all study procedures and comply with all study instruction. * In good health as determined by OMSO (Office of Medical Support and Oversight). * Supervisor approval for federal civilian employees and non-HRV active-duty military personnel stationed at NSSC Exclusion Criteria: * • Unable to understand verbal or written instructions or testing materials in English. * Have a bleeding disorder (e.g., von Willebrand Disease, hemophilia) or are being treated with medication that will impair blood clotting (for example, coumadin) * Have a history of GI-related conditions that may impact macronutrient absorption (e.g., Crohn's disease, ulcerative colitis, Celiac's disease or gluten sensitivity, bariatric surgery or gastroparesis, short bowel, inflammatory bowel disease, etc…); * Any use of antibiotics or antifungal, except topical antibiotics/antifungals within 3 months of study participation. * Colonoscopy within 3 months of study participation. * Regular (i.e., weekly or more frequent) use of over-the-counter medications (including antacids, laxatives, stool softeners, and antidiarrheals) unless approved by OMSO and study PI. * Are habitually taking nonsteroidal anti-inflammatory drugs (e.g., Advil, aspirin), corticosteroids (e.g., prednisone) or immunosuppressants (e.g. Humira); * Have an allergy or aversion (extreme dislike) to any of the test foods(e.g., cherry flavored beverages or bar). Allergy symptoms may include anaphylaxis, hives or eczema, tingling/itching in the mouth, dizziness or fainting, diarrhea, nausea or vomiting, swelling of the lips, face, tongue and throat). * Have donated blood within the past 8 weeks of the first test session or plan to donate blood during the study. * Are not willing to abstain from tobacco products and vigorous exercise for at least 24 hours" before each trial and consume a low-polyphenol diet two days prior to each test session and on the day of the test session.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bioavailability are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
USARIEM
RECRUITINGNatick, Massachusetts, 01760, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.